Generic name | ustekinumab |
Strength | 45 mg/0.5 mL and 90 mg/mL |
Form | syringe |
Special Authority criteria |
Approval period |
---|---|
Treatment of moderate to severe psoriasis, according to established criteria, when prescribed by a dermatologist |
Initial: 3 doses |